Related references
Note: Only part of the references are listed.Proteinase-activated receptor (PAR)-2 activation impacts bone resorptive properties of human osteoarthritic subchondral bone osteoblasts
Nathalie Amiable et al.
BONE (2009)
Osteoprotegerin inhibits cartilage degradation through an effect on trabecular bone in murine experimental osteoarthritis
A. Kadri et al.
ARTHRITIS AND RHEUMATISM (2008)
OPG is regulated by β-catenin and mediates resistance to TRAIL-induced apoptosis in colon cancer
Enrico N. De Toni et al.
CLINICAL CANCER RESEARCH (2008)
Receptor activator of nuclear factor kappa B ligand and osteoprotegerin regulation of bone remodeling in health and disease
Ann E. Kearns et al.
ENDOCRINE REVIEWS (2008)
Prevention of cartilage destruction with intraarticular osteoclastogenesis inhibitory factor/osteoprotegerin in a murine model of osteoarthritis
Sadanori Shimizu et al.
ARTHRITIS AND RHEUMATISM (2007)
Role of osteoprotegerin in arterial calcification development of new animal model
Yuichi Orita et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Differential effects of vitamin D analogs on vascular calcification
Anna Cardus et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2007)
Evaluation of protease-activated receptor 2 in murine models of arthritis
Nathalie Busso et al.
ARTHRITIS AND RHEUMATISM (2007)
Activation of proteinase-activated receptor 2 in human osteoarthritic cartilage upregulates catabolic and proinflammatory pathways capable of inducing cartilage degradation: a basic science study
Christelle Boileau et al.
ARTHRITIS RESEARCH & THERAPY (2007)
Expression of proteinase-activated receptors (PAR)-2 in articular chondrocytes is modulated by IL-1β, TNF-α and TGF-β
Y. Xiang et al.
OSTEOARTHRITIS AND CARTILAGE (2006)
Characterization of osteoprotegerin binding to glycosaminoglycans by surface plasmon resonance:: Role in the interactions with receptor activator of nuclear factor κB ligand (RANKL) and RANK
S. Theoleyre et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Syndecan-1 expression is upregulated in degenerating articular cartilage in a transgenic mouse model for osteoarthritis
H Salminen-Mankonen et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2005)
The regulation of human MMP-13 by licofelone, an inhibitor of cyclo-oxygenases and 5-lipoxygenase, in human osteoarthritic chondrocytes is mediated by the inhibition of the p38 MAP kinase signalling pathway
C Boileau et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
IL-6, RANKL, TNF-alpha/IL-1: interrelations in bone resorption pathophysiology
KT Steeve et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2004)
Differential gene expression and regulation of the bone morphogenetic protein antagonists follistatin and gremlin in normal and osteoarthritic
G Tardif et al.
ARTHRITIS AND RHEUMATISM (2004)
A single-dose placebo-controlled study of AMG 162, a fully human monoclonal antibody to RANKL, in postmenopausal women
PJ Bekker et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2004)
Human bone marrow stromal cells protect prostate cancer cells from TRAIL-induced apoptosis
R Nyambo et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2004)
Role for osteoprotegerin in rheumatoid inflammation
N Saidenberg-Kermanac'h et al.
JOINT BONE SPINE (2004)
Enhanced effector and memory CTL responses generated by incorporation of receptor activator of NF-κB(RANK)/RANK ligand costimulatory molecules into dendritic cell immunogens expressing a human tumor-specific antigen
C Wiethe et al.
JOURNAL OF IMMUNOLOGY (2003)
RANKL and RANK as novel therapeutic targets for arthritis
T Nakashima et al.
CURRENT OPINION IN RHEUMATOLOGY (2003)
Mechanisms of TNF-α- and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis
CT Ritchlin et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Cooperation of TNF family members CD40 ligand, receptor activator of NF-κB ligand, and TNF-α in the activation of dendritic cells and the expansion of viral specific CD8+ T cell memory responses in HIV-1-infected and HIV-1-uninfected individuals
QG Yu et al.
JOURNAL OF IMMUNOLOGY (2003)
Essential role for proteinase-activated receptor-2 in arthritis
WR Ferrell et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Long-lived immature dendritic cells mediated by TRANCE-RANK interaction
I Cremer et al.
BLOOD (2002)
Osteoprotegerin is bound, internalized, and degraded by multiple myeloma cells
T Standal et al.
BLOOD (2002)
Matrix metalloproteinases cleave connective tissue growth factor and reactivate angiogenic activity of vascular endothelial growth factor 165
G Hashimoto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Minireview: The OPG/RANKL/RANK system
S Khosla
ENDOCRINOLOGY (2001)
The ratio of messenger RNA levels of receptor activator of nuclear factor κB ligand to osteoprotegerin correlates with bone remodeling indices in normal human cancellous bone but not in osteoarthritis
NL Fazzalari et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2001)
Matrix metalloproteinases collagenase-2, macrophage elastase, collagenase-3, and membrane type 1-matrix metalloproteinase impair clotting by degradation of fibrinogen and factor XII
O Hiller et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Semiquantitative reverse transcription-polymerase chain reaction analysis of syndecan-1 and-4 messages in cartilage and cultured chondrocytes from osteoarthritic joints
PE Barre et al.
OSTEOARTHRITIS AND CARTILAGE (2000)
Share Paper
